At diaTribe Change, our mission is to improve the lives of people with diabetes and prediabetes through informed policy advocacy...

Launched by the Diabetes Patient Advocacy Coalition, the Patient Pocket Protector Coalition is committed to making drugs more affordable for...

Join the movement to cap the out-of-pocket insurance cost of insulin at $35 per month.

The National Clinical Care Commission - a group of government officials and diabetes experts established to improve federal diabetes prevention...

diaTribe is launching a new website, dStigmatize.org, to provide a comprehensive resource for understanding, reducing, and ending diabetes stigma. Reducing...

The International Diabetes Federation (IDF) released their 10th edition of the IDF Diabetes Atlas, an annual report of global estimates...

The American Diabetes Association released its 2022 Standards of Care, which provides its annual update on practice guidelines. Here's what...

diaTribe Change supports a drug pricing plan part of the Build Back Better Act that includes an insulin copay cap,...

Time in Range, a metric most often calculated using a CGM, is a valuable glucose management tool that people with...

The FDA has denied approval of teplizumab, the first disease-modifying drug that could prevent the onset of type 1 diabetes....